TMCI

Treace Medical Concepts, Inc.

Healthcare · $282M market cap

Verdict

We can't put a fair value on TMCI right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth-6.9% a year✗
Sales growth38.2% a year✓
Free cash flow growth—?
Return on invested capital-29.7%✗

Follow TMCI

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

None of the investors we track holds TMCI right now. In Q1 2026, 1 sold out. Who we track

Moves in Q1 2026

Sold out: First Eagle Investment Management

About Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works

TMCI stock (Treace Medical Concepts, Inc.): ownership and insider trades — PaybackPrice